Medical/Pharmaceuticals
Asia Pacific Initiative on Reproduction (ASPIRE) 2022 Congress: Greater sense of patient empowerment with telemedicine trends in IVF services
SINGAPORE, April 29, 2022 /PRNewswire/ -- Telemedicine that became a vital engagement tool between health professionals and patients during the COVID-19 pandemic is emerging as a welcome new treatment of choice among fertility clinics and couples striving for parenthood. Patients seeking assiste...
Transcenta to Present Clinical Trial Data of TST001 and MSB0254 at 2022 ASCO Annual Meeting
SUZHOU, China, April 29, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that the abstracts o...
Promising COVID oral antiviral being co-researched by Healion Bio and FUJIFILM Toyama
FREDERICK, Md., April 29, 2022 /PRNewswire/ -- Healion Bio, a closely held biotechnology company, today announced a collaborative agreement to research a combination antiviral against SARS-CoV-2 and other deadly pathogens. The combination will include one of Healion Bio's protease inhibitors and ...
Varian partners with Icon Group to advance patient-centric solutions
Bringing clinical insights into early product development PALO ALTO, Calif. and SYDNEY, April 28, 2022 /PRNewswire/ -- Varian, a Siemens Healthineers company (Varian), today announced a five-year research and professional services agreement with Icon Group (Icon). Through this agreement, Icon wi...
United Imaging Healthcare bags Healthcare Asia Medtech Award
SHANGHAI, April 28, 2022 /PRNewswire/ -- United Imaging Healthcare was recognised with the Imaging Product Innovation of the Year Award at the Healthcare Asia Medtech Awards with its three groundbreaking products: the Total-body PET/CT uEXPLORER, the 3.0T uMR Omega, and uRT-linac 506c. United Im...
Transcenta Announces First Patient Dosed in China Study of Anti-sclerostin Monoclonal Antibody TST002 for the Treatment of Osteoporosis
SUZHOU, China, April 28, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces the successful dosin...
The Danish National Genome Center Partners with Lifebit to Deliver Nationwide Personalised Medicine
The Danish National Genome Center has awarded Lifebit a four-year contract to implement Lifebit's Federated Trusted Research Environment software, Lifebit CloudOS, withinDenmark's national supercomputing center. LONDON, April 28, 2022 /PRNewswire/ -- Lifebit, whose leading technology enable...
HealthBeats Raises US$3m Seed Funding Led By Heritas Capital And SEEDS Capital To Expand Remote Vitals Monitoring In Australia And Singapore
SINGAPORE and SYDNEY and NEW YORK, April 28, 2022 /PRNewswire/ -- HealthBeatsTM , aSingapore-based healthtech start-up with end-to-end remote vitals monitoring solution, today announced the close of aUS$3m Seed round led by healthcare investor Heritas Capital together with SEEDS Capital, the inves...
CStone to present the latest clinical results of anti-PD-L1 antibody sugemalimab and anti-PD-1 antibody nofazinlimab at ASCO 2022
* Results from GEMSTONE-201 study of sugemalimab, the first successful registrational clinical study to date evaluating an anti-PD-(L)1 antibody targeting patients with relapsed or refractory extranodal natural killer/T-cell lymphoma, will be presented in an oral abstract session * The protoc...
Zimmer Biomet's mymobility is recognized as "The Care Management Initiative of the Year" by the 2022 Healthcare Asia Medtech Awards
SINGAPORE, April 28, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that the company's mymobility® digital care management platform won "The Care Management Initiative of the Year" award at this year's Healthcare Asia Med...
Glooko Appoints Alfonso "Chito" Zulueta, former Eli Lilly & Company Senior Executive, to Board of Directors
PALO ALTO, Calif., April 28, 2022 /PRNewswire/ -- Glooko, Inc., a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the appointment of Alfonso "Chito" Zulueta to its Board of Directors. Respected as a leader w...
3M Petrifilm Plate Reader Advanced wins gold at 2022 Edison Awards
ST. PAUL, Minn., April 27, 2022 /PRNewswire/ -- 3M Food Safety was named a 2022 Edison Awards™ gold winner in the Commercial Technology category for its 3M™ Petrifilm™ Plate Reader Advanced. The Edison Awards globally recognize, honor and foster innovations and innovators whose solutions make a p...
HistoIndex and Global Liver Experts Advance Stain-free AI Quantification of Hepatocyte Ballooning as a Reproducible Approach and Potential Endpoint for NASH Clinical Trials
* This is a first-of-its-kind international study initiated in 2019 by HistoIndex to examine artificial intelligence (AI)-based approaches that may provide a more reliable way to assess the range of injury recorded as "hepatocyte ballooning" as a clinical trial endpoint by expert hepatopatholo...
Zymo Research Makes Strategic Investment in Star Array to Develop an Automated Nucleic Acid Extraction/Superfast PCR Platform for the POCT Market
IRVINE, Calif., April 27, 2022 /PRNewswire/ -- Zymo Research and Star Array today announced Zymo Research's strategic investment to acquire an interest in Star Array, a privately owned, biomedical technology company based inSingapore. The investment allows Zymo Research and Star Array to combine ...
Antengene Announces Submission to the Human Research Ethics Committee in Australia for a Phase I Trial of ATG-018
* Developed in-house by internal R&D Team at Antengene, ATG-018 is an orally-available, small molecule ATR inhibitor that targets DNA Damage Response (DDR) pathways. * The Phase I study will evaluate the safety, pharmacology and preliminary efficacy of ATG-018 in patients with advanced solid ...
VISTA Eye Specialist (VISTA) Opens its 12th Outlet with Massive Success
PETALING JAYA, Malaysia, April 27, 2022 /PRNewswire/ -- VISTA officially opened
inMalaysia's 5th largest city - Ipoh, marking its 12th outlet in the country.
It presently has seven branches in Klang Valley, three inPenang (Northern
Malaysia) and one in Johor Bahru (Southern Malaysia).
Taiyo Corporation Introducing OPELAIII "Subscription Style" Rental Purchase Plan
Once subscription ends, the units can be redistributed as used equipment to countries with strong demands and thereby meet SDGs requirement TOKYO, April 27, 2022 /PRNewswire/ -- Taiyo Corporation (Headquarter: Tokyo, Japan / President: Mariko Koizumi), the manufacturer of Wearable Surgical Light...
Treadwell Therapeutics Announces Fast Track Designation Granted by the FDA to CFI-400945 for the Treatment of Acute Myeloid Leukemia
NEW YORK and HONG KONG, April 27, 2022 /PRNewswire/ -- Treadwell Therapeutics, a clinical-stage biotechnology company developing novel medicines for unmet needs in cancer, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to CFI-400945, a first in...
FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial
AUSTIN, Texas, April 27, 2022 /PRNewswire/ -- Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV ...
Seegene unveils world's first commercialized '3 Ct' PCR assay
* Provides Ct value of three targets in one channel; '3 Ct' PCR assay to launch in H1 * "Dream MDx technology" developed based on Seegene's 20-year expertise; combines 19 different patented technologies, including DPO™, TOCE™, MuDT™ * '3 Ct' to lay foundation for automated syndromic testing ...
Week's Top Stories
Most Reposted
k-ID Closes $45 Million Series A from Andreessen Horowitz and Lightspeed Venture Partners to Set a New Global Benchmark for Age-appropriate Gaming Experiences
[Picked up by 320 media titles]
2024-06-25 21:0010 Start-ups Awarded in HK Tech 300 Southeast Asia Start-up Competition Fostering Innovation & Entrepreneurship Beyond Boundaries
[Picked up by 317 media titles]
2024-06-27 18:56Labuan IBFC Inc. and STEP Malaysia jointly host wealth management and estate planning event
[Picked up by 315 media titles]
2024-06-28 12:45SCO strengthening youth development for better future
[Picked up by 297 media titles]
2024-06-24 10:52Fibocom Drives the Rapid Growth in the Economics of IoT Scale with Ultra-compact size Cat 1 bis Module MC610-GL at MWC Shanghai 2024
[Picked up by 286 media titles]
2024-06-26 10:00